Alejandra Carvajal
2021
Compensation breakdown
Non-Equity Incentive Plan | $107,712 |
---|---|
Option Awards | $1,346,209 |
Salary | $274,359 |
Stock Awards | $449,970 |
Total | $2,178,250 |
Carvajal received $1.3M in option awards, accounting for 62% of the total pay in 2021.
Carvajal also received $107.7K in non-equity incentive plan, $274.4K in salary and $450K in stock awards.
Rankings
In 2021, Alejandra Carvajal's compensation ranked 5,728th out of 12,415 executives tracked by ExecPay. In other words, Carvajal earned more than 53.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,728 | 54th |
Manufacturing | 2,428 | 56th |
Chemicals And Allied Products | 1,052 | 56th |
Drugs | 939 | 55th |
Pharmaceutical Preparations | 676 | 56th |
Pay ratio
Alejandra Carvajal's Pay | $2,178,250 |
---|---|
Median Employee's Pay | $302,642 |
Pay Ratio | 7to 1 |
In 2021, the annual total compensation of Alejandra Carvajal was $2,178,250.
The annual total compensation of the median employee at Mersana Therapeutics was $302,642.
The ratio of Alejandra Carvajal's pay to the pay of median employee was therefore 7 to one.
Carvajal's colleagues
We found six more compensation records of executives who worked with Alejandra Carvajal at Mersana Therapeutics in 2021.
2021
Anna Protopapas
Mersana Therapeutics
Chief Executive Officer
2021
Timothy Lowinger
Mersana Therapeutics
Senior Vice President, Chief Science and Technology Officer
2021
Brian DeSchuytner
Mersana Therapeutics
Chief Financial Officer
2021
Michael Kaufman
Mersana Therapeutics
Former Chief Manufacturing Officer
2021
Tushar Misra
Mersana Therapeutics
Senior Vice President, Chief Manufacturing Officer
2021
Arvin Yang
Mersana Therapeutics